SIMBRINZA 1%-0.2% EYE DROP

brinzolamide/brimonidine tartrate
$26.0684per ML

Strength

2; 10 mg/mL; mg/mL

NDC

00065414727

Classification

Brand

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Last Updated

1/1/2026

Approval Type

New Drug (NDA)

FDA Application

NDA204251

On Market Since

5/6/2013

Pharmacological Classes

Adrenergic alpha-Agonists
Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.1%

1Y

+2.9%

3Y

+9.4%

5Y

+19.7%

All

+145.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.